Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
Clinical trial NCT01925573 · TERMINATED
Trial details
- NCT number
- NCT01925573
- Sponsor
- University of Maryland, Baltimore
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2019-08-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.